162 related articles for article (PubMed ID: 31126574)
1. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Maleki Z; Jazayeri S; Eslami O; Shidfar F; Hosseini AF; Agah S; Norouzi H
Complement Ther Med; 2019 Jun; 44():44-50. PubMed ID: 31126574
[TBL] [Abstract][Full Text] [Related]
2. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial.
Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Azadbakht L
Nutrition; 2014; 30(7-8):814-21. PubMed ID: 24984998
[TBL] [Abstract][Full Text] [Related]
3. Effect of Soy Milk on Metabolic Status of Patients with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
Eslami O; Shidfar F; Maleki Z; Jazayeri S; Hosseini AF; Agah S; Ardiyani F
J Am Coll Nutr; 2019 Jan; 38(1):51-58. PubMed ID: 30028245
[TBL] [Abstract][Full Text] [Related]
4. Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial.
Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Haghighatdoost F; Azadbakht L
Horm Metab Res; 2017 Sep; 49(9):687-692. PubMed ID: 28759939
[TBL] [Abstract][Full Text] [Related]
5. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
[TBL] [Abstract][Full Text] [Related]
6. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
[TBL] [Abstract][Full Text] [Related]
7. The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
Kazemi S; Shidfar F; Ehsani S; Adibi P; Janani L; Eslami O
Complement Ther Clin Pract; 2020 Nov; 41():101259. PubMed ID: 33190008
[TBL] [Abstract][Full Text] [Related]
8. The effect of apple vinegar consumption on glycemic indices, blood pressure, oxidative stress, and homocysteine in patients with type 2 diabetes and dyslipidemia: A randomized controlled clinical trial.
Gheflati A; Bashiri R; Ghadiri-Anari A; Reza JZ; Kord MT; Nadjarzadeh A
Clin Nutr ESPEN; 2019 Oct; 33():132-138. PubMed ID: 31451249
[TBL] [Abstract][Full Text] [Related]
9. The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial.
Gheflati A; Adelnia E; Nadjarzadeh A
Phytother Res; 2019 May; 33(5):1501-1509. PubMed ID: 30895694
[TBL] [Abstract][Full Text] [Related]
10. The effects of zinc supplementation on metabolic profile and oxidative stress in overweight/obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
Fathi M; Alavinejad P; Haidari Z; Amani R
J Trace Elem Med Biol; 2020 Dec; 62():126635. PubMed ID: 32932174
[TBL] [Abstract][Full Text] [Related]
11. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
[TBL] [Abstract][Full Text] [Related]
12. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
Nikbaf-Shandiz M; Tutunchi H; Khoshbaten M; Nazari Bonab H; Ebrahimi-Mameghani M
Food Funct; 2022 Nov; 13(22):11568-11578. PubMed ID: 36263703
[TBL] [Abstract][Full Text] [Related]
13. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.
Köroğlu E; Canbakan B; Atay K; Hatemi İ; Tuncer M; Dobrucalı A; Sonsuz A; Gültepe I; Şentürk H
Turk J Gastroenterol; 2016 Jul; 27(4):361-6. PubMed ID: 27458852
[TBL] [Abstract][Full Text] [Related]
14. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD.
Hossain IA; Rahman Shah MM; Rahman MK; Ali L
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S25-9. PubMed ID: 26482965
[TBL] [Abstract][Full Text] [Related]
15. The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial.
Neshatbini Tehrani A; Hatami B; Daftari G; Hekmatdoost A; Yari Z; Salehpour A; Hosseini SA; Helli B
BMC Public Health; 2024 May; 24(1):1362. PubMed ID: 38773414
[TBL] [Abstract][Full Text] [Related]
16. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases.
Navekar R; Rafraf M; Ghaffari A; Asghari-Jafarabadi M; Khoshbaten M
J Am Coll Nutr; 2017; 36(4):261-267. PubMed ID: 28443702
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Probiotic Soy Milk Consumption on Oxidative Stress Among Type 2 Diabetic Kidney Disease Patients: A Randomized Controlled Clinical Trial.
Miraghajani M; Zaghian N; Mirlohi M; Feizi A; Ghiasvand R
J Ren Nutr; 2017 Sep; 27(5):317-324. PubMed ID: 28579313
[TBL] [Abstract][Full Text] [Related]
18. Soy milk consumption and blood pressure among type 2 diabetic patients with nephropathy.
Miraghajani MS; Najafabadi MM; Surkan PJ; Esmaillzadeh A; Mirlohi M; Azadbakht L
J Ren Nutr; 2013 Jul; 23(4):277-282.e1. PubMed ID: 23498346
[TBL] [Abstract][Full Text] [Related]
19. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
[TBL] [Abstract][Full Text] [Related]
20. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
